In 2008, Professor Meng Qingyun, a well-known domestic asthma expert (former president of Hebei Xianghe Asthma Hospital), was invited to join the Star Hospital of Beijing Medical University, set up an asthma specialist, and jointly received asthma patients nationwide with the 66055 Military Hospital of the People's Liberation Army.
Asthma specialist of traditional Chinese medicine adopts acupoint injection of specific drugs combined with oral administration of traditional Chinese medicine to achieve the purpose of treatment. After numerous clinical case observations, after treatment, the patient recovered from pathological damage through X-ray, electrocardiogram and other examinations, and his conscious symptoms disappeared. Therefore, a new method of treating chronic bronchitis, bronchial asthma, emphysema and pulmonary heart disease based on traditional Chinese medicine, which treats both the symptoms and the root causes, implements syndrome differentiation and combines acupoint injection with oral Chinese medicine, has been declared successful. This characteristic therapy has cured more than 40,000 patients at home and abroad. Professor Meng's invention won the national patent award and became the promotion project of characteristic therapy in China Bureau of Traditional Chinese Medicine. Professor Meng has been a doctor for 50 years, and has won more than 300 honorary certificates, more than 500 banners and donated more than 200 calligraphy and paintings, which has been received by the government and relevant leaders for more than 200 times.
More than a dozen news organizations, such as People's Daily, China Daily, Health Daily, Guangming Daily, the Central Committee of the Communist Youth League, and TV stations, also reported Professor Meng Qingyun's treatment of asthma. He determined his own treatment plan by treating both the symptoms and root causes of traditional Chinese medicine and combining modern diagnosis and treatment methods. He developed a set of drugs to treat chronic bronchitis in remission, a set of drugs to treat cor pulmonale in remission, a set of drugs to treat bronchial asthma, and a set of drugs to treat bronchiectasis, and obtained 5 contemporary invention patents in China National Intellectual Property Administration. The research on the treatment of bronchial asthma with integrated traditional Chinese and western medicine won the certificate of scientific and technological achievements in Hebei Province and the first prize of scientific and technological progress in Langfang City. Experts agree that this achievement has made a breakthrough in the treatment of bronchial asthma. Compared with other similar technologies, this achievement has the advantages of simple operation, quick curative effect, low recurrence rate, low cost, scientificity, advancement and popularization and application value, and the curative effect has reached the leading level in China.